Creative Planning - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 128 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.7%.

Quarter-by-quarter ownership
Creative Planning ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2019$242,000
+112.3%
21,0000.0%0.00%
Q3 2019$114,000
-52.1%
21,000
+5.0%
0.00%
-100.0%
Q2 2019$238,000
+126.7%
20,0000.0%0.00%
Q1 2019$105,000
+66.7%
20,0000.0%0.00%
Q4 2018$63,000
-55.0%
20,000
-13.3%
0.00%
-100.0%
Q3 2018$140,000
+15.7%
23,070
+0.9%
0.00%
Q2 2018$121,000
+61.3%
22,870
+76.8%
0.00%
Q1 2018$75,00012,9330.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,109,867$42,332,00029.76%
Versant Venture Management, LLC 7,003,892$72,140,00013.20%
Ghost Tree Capital, LLC 1,161,375$11,962,0003.46%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,944,0002.54%
Soleus Capital Management, L.P. 364,349$3,753,0001.99%
RTW INVESTMENTS, LP 7,234,764$74,518,0001.79%
RA Capital Management 9,410,860$96,932,0001.77%
FRAZIER MANAGEMENT LLC 1,437,028$14,801,0001.33%
Casdin Capital, LLC 2,750,000$28,325,0001.27%
Avoro Capital Advisors LLC 8,000,000$82,400,0001.17%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders